Brief: Kiromic BiopharmaOn May 11, Nasdaq Hearings Panel Granted Request For Extension Until Sept 11, For Co To Comply With Stockholders’ Equity Requirement
12/05/2023 21:42
Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA:ON MAY 11, NASDAQ HEARINGS PANEL GRANTED
REQUEST FOR EXTENSION UNTIL SEPT 11, FOR CO TO COMPLY WITH
STOCKHOLDERS’ EQUITY REQUIREMENT
Source text for Eikon: ID:
Further company coverage: KRBP.O
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site